132 related articles for article (PubMed ID: 1676282)
1. HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS.
Shafer RW; Chirgwin KD; Glatt AE; Dahdouh MA; Landesman SH; Suster B
AIDS; 1991 Apr; 5(4):399-405. PubMed ID: 1676282
[TBL] [Abstract][Full Text] [Related]
2. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition.
Stoneburner R; Laroche E; Prevots R; Singh T; Blum S; Terry P; Reatrice S; Adler J
Arch Intern Med; 1992 Oct; 152(10):2033-7. PubMed ID: 1358042
[TBL] [Abstract][Full Text] [Related]
3. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of tuberculosis associated with HIV infection in Taiwan.
Hsieh SM; Hung CC; Chen MY; Chang SC; Hsueh PR; Luh KT; Chuang CY
J Formos Med Assoc; 1996 Dec; 95(12):923-8. PubMed ID: 9000809
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus infection in tuberculosis patients.
Theuer CP; Hopewell PC; Elias D; Schecter GF; Rutherford GW; Chaisson RE
J Infect Dis; 1990 Jul; 162(1):8-12. PubMed ID: 1972384
[TBL] [Abstract][Full Text] [Related]
7. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
Vernon A; Burman W; Benator D; Khan A; Bozeman L
Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
[TBL] [Abstract][Full Text] [Related]
8. Rifampin-monoresistant tuberculosis in New York City, 1993-1994.
Munsiff SS; Joseph S; Ebrahimzadeh A; Frieden TR
Clin Infect Dis; 1997 Dec; 25(6):1465-7. PubMed ID: 9431396
[TBL] [Abstract][Full Text] [Related]
9. CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection.
Keiper MD; Beumont M; Elshami A; Langlotz CP; Miller WT
Chest; 1995 Jan; 107(1):74-80. PubMed ID: 7813316
[TBL] [Abstract][Full Text] [Related]
10. The emergence of drug-resistant tuberculosis in New York City.
Frieden TR; Sterling T; Pablos-Mendez A; Kilburn JO; Cauthen GM; Dooley SW
N Engl J Med; 1993 Feb; 328(8):521-6. PubMed ID: 8381207
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
12. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.
Frieden TR; Sherman LF; Maw KL; Fujiwara PI; Crawford JT; Nivin B; Sharp V; Hewlett D; Brudney K; Alland D; Kreisworth BN
JAMA; 1996 Oct; 276(15):1229-35. PubMed ID: 8849750
[TBL] [Abstract][Full Text] [Related]
13. Acute and long-term efficacy of antituberculous treatment in HIV-seropositive patients with tuberculosis: a study of 36 cases.
Schürmann D; Bergmann F; Jautzke G; Fehrenbach J; Mauch H; Ruf B
J Infect; 1993 Jan; 26(1):45-54. PubMed ID: 8454888
[TBL] [Abstract][Full Text] [Related]
14. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of multidrug-resistant tuberculosis at a hospital--New York City, 1991.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1993 Jun; 42(22):427, 433-4. PubMed ID: 8502215
[TBL] [Abstract][Full Text] [Related]
16. Prevention of lung infections associated with human immunodeficiency virus infection.
Hopewell PC
Thorax; 1989 Dec; 44(12):1038-44. PubMed ID: 2575801
[TBL] [Abstract][Full Text] [Related]
17. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group.
Hanson DL; Chu SY; Farizo KM; Ward JW
Arch Intern Med; 1995 Jul; 155(14):1537-42. PubMed ID: 7605156
[TBL] [Abstract][Full Text] [Related]
18. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
Small PM; Schecter GF; Goodman PC; Sande MA; Chaisson RE; Hopewell PC
N Engl J Med; 1991 Jan; 324(5):289-94. PubMed ID: 1898769
[TBL] [Abstract][Full Text] [Related]
19. Failure of therapy for tuberculosis in human immunodeficiency virus infection.
Nolan CM
Am J Med Sci; 1992 Sep; 304(3):168-73. PubMed ID: 1476156
[TBL] [Abstract][Full Text] [Related]
20. Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.
Sterling TR; Alwood K; Gachuhi R; Coggin W; Blazes D; Bishai WR; Chaisson RE
AIDS; 1999 Oct; 13(14):1899-904. PubMed ID: 10513648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
